Literature DB >> 9094069

In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy.

C Boesch1, J Slotboom, H Hoppeler, R Kreis.   

Abstract

Intra-myocellular lipids (IMCL) are stored in droplets in the cytoplasm of muscle cells and are an energy storage form readily accessed during long-term exercise. 1H-MR spectroscopy methods are presented for noninvasive determination of IMCL in human muscle. This is based on (a) the separation of two resonances in the lipid-CH2-region, with the one assigned to IMCL being independent of muscle orientation relative to the magnetic field and (b) the fact that IMCL resonances scale along with signal amplitudes of metabolites in the muscle cell (e.g., creatine) when voxel size is increased, while lipid signals of bulk fat show a disproportionate growth. Inter-individual and intra-individual reproducibility studies indicate that the error of the method is about 6% and that IMCL levels differ significantly between identical muscles in different subjects, as well as intra-individually when measured at 1 week intervals. IMCL determinations in a single subject before and after strenuous exercise indicate that lipid stores recover with a t1/2 of about 1 day.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094069     DOI: 10.1002/mrm.1910370403

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  108 in total

1.  Effects of intermittent cycle exercise on intramyocellular lipid use and recovery.

Authors:  Lesley J White; Robert A Robergs; Wilmer L Sibbitt; Michael A Ferguson; Sean McCoy; William M Brooks
Journal:  Lipids       Date:  2003-01       Impact factor: 1.880

Review 2.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 3.  Ectopic fat accumulation: an important cause of insulin resistance in humans.

Authors:  Hannele Yki-Järvinen
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 4.  Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 5.  The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans.

Authors:  Martin Krssak; Michael Roden
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

6.  Intramyocellular lipids: maker vs. marker of insulin resistance.

Authors:  Zengkui Guo
Journal:  Med Hypotheses       Date:  2007-09-04       Impact factor: 1.538

Review 7.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state.

Authors:  Luc J C van Loon; Rene Koopman; Jos H C H Stegen; Anton J M Wagenmakers; Hans A Keizer; Wim H M Saris
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

9.  Quantum coherence spectroscopy to measure dietary fat retention in the liver.

Authors:  Lucas Lindeboom; Robin A de Graaf; Christine I Nabuurs; Petronella A van Ewijk; Matthijs Kc Hesselink; Joachim E Wildberger; Patrick Schrauwen; Vera B Schrauwen-Hinderling
Journal:  JCI Insight       Date:  2016-08-18

10.  Distinct patterns of fat metabolism in skeletal muscle of normal-weight, overweight, and obese humans.

Authors:  S Sendhil Velan; Nicholas Said; Christopher Durst; Stephanie Frisbee; Jefferson Frisbee; Raymond R Raylman; M Albert Thomas; Vazhaikkurichi M Rajendran; Richard G Spencer; Stephen E Alway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.